A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)

Sex: All

Ages: 18 Years – 64 Years

Healthy volunteers: Yes

Phase: PHASE1

Enrollment: 400

Sponsor: Merck Sharp & Dohme LLC

Summary

The purpose of this trial is to compare what happens to MK-1406 in the body of healthy participants when it is given as 2-injections and 3-injections. Researchers also want to learn about the safety of MK-1406 and if people tolerate it.

Eligibility Criteria

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: * Is in good health * Has body mass index (BMI) 18.0 to 32.0 kg/m\^2 Exclusion Criteria: The main exclusion criteria include but are not limited to the following: * History of clinically significant endocrine, Gastrointestinal (GI), cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases * History of cancer (malignancy)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07743151). StuddyBuddy aggregates publicly available trial information.